MAS1L and COVID-19: Upregulating ACE2, IL-10 can help to restore RAAS balance, with a reduction of ACE/Ang II/AT1R axis and an increase of ACE2/Ang-(1–7)/MasR axis, resulting in beneficial effects on COVID-19 and post-COVID-19 symptoms.